Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-18,800
Closed -$415K 10833
2019
Q2
$415K Buy
18,800
+7,800
+71% +$181K ﹤0.01% 7657
2019
Q1
$260K Buy
+11,000
New +$257K ﹤0.01% 7469
2018
Q2
Sell
-17,700
Closed -$458K 10406
2018
Q1
$458K Buy
+17,700
New +$484K ﹤0.01% 6818
2017
Q4
Sell
-102,800
Closed -$2.31M 9882
2017
Q3
$2.31M Buy
102,800
+83,200
+424% +$1.88M ﹤0.01% 3646
2017
Q2
$519K Buy
+19,600
New +$523K ﹤0.01% 6575
2017
Q1
Sell
-10,800
Closed -$266K 9926
2016
Q4
$266K Sell
10,800
-1,400
-11% -$29.5K ﹤0.01% 8189
2016
Q3
$276K Sell
12,200
-3,000
-20% -$65.5K ﹤0.01% 7069
2016
Q2
$288K Buy
+15,200
New +$317K ﹤0.01% 7031

Other funds holding TBI

Jeff Yass's TBI Position: Q2 2026 in Review

Jeff Yass sold out of Trueblue (TBI) in Q2 2026, closing a stake of 29,267 shares — an estimated $114K sold.

Jeff Yass first reported a position in TBI in Q4 2013 and held it in 25 quarters. The position peaked at $2.39M in Q3 2014. 113 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Jeff Yass reported no remaining Trueblue position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 29,267 Trueblue shares in Q2 2026, an estimated $114K.
  • Jeff Yass first reported a position in Trueblue in Q4 2013 and held it in 25 quarters.
  • Jeff Yass's Trueblue position peaked at $2.39M in Q3 2014.
  • 113 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.